Together, these results position epithelial YY1–FTL–GPX4 signaling as a central upstream axis that couples environmental nanoplastic exposure to ferroptosis dependent fibrotic remodeling and highlight epithelial YY1 and ferroptosis as attractive therapeutic targets for nanoplastic related lung fibrosis. The gene discussed is FTL; the disease is pulmonary fibrosis.